ConditionCancer

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced peripheral neuropathy (CIPN) is nerve damage caused by some cancer medicines, especially platinum drugs, taxanes, vinca alkaloids and bortezomib. It typically causes numbness, tingling, burning pain and sensitivity in the fingers and toes, spreading upward in a "glove and stocking" pattern, and can affect balance and fine hand movements. It often improves over months after treatment ends, but can be permanent. Reporting symptoms early lets your oncologist adjust the dose before damage becomes severe.

Also called: CIPN, chemo neuropathy, chemotherapy-induced peripheral neuropathy, chemo feet

At a glance

What it is
Damage to peripheral nerves from certain chemotherapy drugs.
Main drugs
Oxaliplatin, cisplatin, paclitaxel, docetaxel, vincristine, bortezomib, thalidomide, eribulin.
Symptoms
Numbness, tingling, burning or shooting pain in fingers and toes; clumsiness; poor balance; cold sensitivity.
How common
Affects most people in the first months of neurotoxic chemo; about 1 in 3 still have symptoms 6 months after.
Treatment
Dose reduction or delay; duloxetine for pain; physical therapy, fall prevention and foot care.

When to get help

Call 911 or go to the ER

  • Sudden weakness of the legs, loss of bladder or bowel control, or numbness in the saddle area
  • Fever of 38 °C (100.4 °F) or higher during chemotherapy (possible infection with low white cells)
  • A foot wound with spreading redness, swelling or pus during chemotherapy

See a doctor within a day or two

  • Numbness or tingling that is getting worse between treatment cycles
  • Trouble buttoning, writing, holding objects or walking
  • Falls or near-falls
  • Severe constipation, dizziness on standing or bladder problems during vincristine or other neurotoxic chemo
  • Throat tightness or difficulty swallowing with cold drinks after oxaliplatin (usually short-lived, but report it)

Book a routine appointment

  • Mild tingling in fingers or toes during chemotherapy: report it at every visit
  • Lingering numbness or pain months after finishing chemo

How chemotherapy damages nerves

Chemotherapy targets rapidly dividing cancer cells, but some drugs also injure peripheral nerves, which have very long fibers. The longest nerves, those reaching the toes and fingertips, are affected first. Different drugs damage different parts of the nerve: the cell body (platinum drugs), the internal transport system (taxanes, vinca alkaloids), or the energy supply (mitochondria).

Chemotherapy drugs that cause neuropathy

Drug classExamplesFeatures
Platinum compoundsOxaliplatin, cisplatin, carboplatin (less)Mostly sensory; oxaliplatin also causes acute cold sensitivity; may worsen for months after stopping ("coasting")
TaxanesPaclitaxel, docetaxel, nab-paclitaxelNumbness and pain in hands and feet; can start quickly
Vinca alkaloidsVincristine, vinblastineSensory and motor; constipation, foot drop, jaw pain
Proteasome inhibitorsBortezomibPainful sensory neuropathy; less with weekly or under-the-skin dosing
ImmunomodulatorsThalidomideCumulative sensory neuropathy
OthersEribulin, ixabepilone, brentuximab vedotin, polatuzumabSensory neuropathy

Symptoms

Sensory symptoms (most common)

  • numbness or reduced feeling in the fingers and toes
  • tingling, pins and needles or "electric" sensations
  • burning or shooting pain
  • sensitivity to touch or cold
  • feeling as if wearing gloves or socks when you are not

Motor and balance symptoms

  • difficulty with buttons, zips, writing or picking up small objects
  • weakness, cramps or foot drop (tripping)
  • unsteadiness, especially in the dark, because you cannot feel where your feet are
  • higher risk of falls

Autonomic symptoms

  • constipation (especially with vincristine)
  • dizziness on standing
  • bladder or sexual dysfunction

Oxaliplatin cold sensitivity

Within hours to days of an oxaliplatin infusion, many people feel tingling around the mouth, in the hands and in the throat when exposed to cold drinks, food or air. It usually settles within a week but can recur with each cycle. Avoid cold drinks and wear gloves for a few days after each dose.

Risk factors

  • higher cumulative dose and dose per cycle
  • combining neurotoxic drugs
  • existing neuropathy, especially from diabetes
  • heavy alcohol use
  • older age
  • vitamin B12 deficiency
  • some inherited neuropathies

Diagnosis

CIPN is diagnosed by your oncology team from your symptoms, timing and an examination of sensation, reflexes, strength and balance. They grade severity (mild symptoms, interference with daily activities, or limiting self-care). Blood tests may check B12, thyroid and blood sugar to rule out other causes. Nerve conduction studies are used if the picture is unclear.

Treatment

Changing chemotherapy

The most effective way to limit CIPN is early detection and adjusting treatment: reducing the dose, delaying a cycle, switching to a different schedule or drug, or stopping the neurotoxic drug. Your oncologist balances this against the cancer benefit, so report symptoms honestly at each visit.

Medicines for painful CIPN

  • Duloxetine: the only medicine with good evidence for painful CIPN, recommended by ASCO.
  • Other options with limited evidence: gabapentin, pregabalin, tricyclic antidepressants, topical treatments such as menthol, capsaicin or lidocaine.

No supplement or medicine has been proven to prevent CIPN.

Prevention approaches being studied

Cooling (frozen gloves and socks) or compression of the hands and feet during taxane infusions may reduce CIPN in some studies, and some cancer centers offer them. Ask your care team.

Physical therapy and exercise

  • Balance and strength training reduce falls.
  • Occupational therapy provides aids for buttons, jars and writing.
  • Regular moderate exercise may ease symptoms.

Living with CIPN

  • Check your feet daily for cuts, blisters or redness you may not feel.
  • Wear well-fitting, closed shoes indoors and out.
  • Test bath water with your elbow or a thermometer to avoid burns.
  • Use night lights and remove tripping hazards; use handrails.
  • Wear gloves for cold weather and when handling cold items.
  • Limit alcohol, which worsens nerve damage.
  • Do not drive if you cannot feel the pedals properly.

Outlook

Many people improve gradually over 6 to 24 months after chemotherapy ends, especially with mild symptoms. Recovery from taxane neuropathy is often better than from platinum neuropathy. Oxaliplatin and cisplatin neuropathy can worsen for 2 to 3 months after the last dose before improving. Some people are left with permanent symptoms, usually numbness in the toes.

Frequently asked questions

Which chemo drugs cause neuropathy?

The main ones are platinum drugs (oxaliplatin, cisplatin), taxanes (paclitaxel, docetaxel), vinca alkaloids (vincristine), bortezomib, thalidomide and eribulin. The risk depends on the drug, the dose and how long treatment lasts.

Does chemo neuropathy go away?

Often it improves, especially if mild. Most recovery happens over 6 to 24 months after treatment. Platinum-related neuropathy may get worse for a few months after stopping before it improves. Some people have permanent numbness or tingling.

What helps neuropathy from chemo?

Duloxetine is the best-supported medicine for painful chemotherapy neuropathy. Physical therapy, balance exercises, foot care, safety changes at home and limiting alcohol also help. Reporting symptoms early allows your oncologist to adjust the dose to prevent worsening.

Can chemo neuropathy be prevented?

No medicine has been proven to prevent it. Early reporting so your doctor can adjust treatment is the most effective strategy. Cooling or compression of the hands and feet during some infusions may reduce risk and is offered at some centers.

Is it safe to exercise with chemo neuropathy?

Yes, and it is encouraged. Balance and strength exercises reduce falls and may ease symptoms. Choose low-impact activities such as walking, cycling on a stationary bike or swimming, wear supportive shoes, and check your feet afterward.

Sources

This guide was written from current patient and clinical guidance, including:

  • American Society of Clinical Oncology (ASCO): Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers, guideline update (2020)
  • National Cancer Institute: Nerve problems (peripheral neuropathy) and cancer treatment
  • American Cancer Society: Peripheral neuropathy caused by chemotherapy
  • NCCN Guidelines: Survivorship
  • Cancer Research UK: Peripheral neuropathy